Pull to refresh
Logo
Johns Hopkins University

Johns Hopkins University

Research university

Appears in 5 stories · Last updated Nov 1, 2026

Stories

FDA clears NeuroXT's NEXT-Cue for Alzheimer's risk prediction

New Capabilities

Research partner to NeuroXT

For years, software that reads a brain scan has been cleared to report what is visible now: a bleed, a lesion, a narrowed vessel. NEXT-Cue is cleared to report something else — how likely a patient already diagnosed with mild cognitive impairment is to develop Alzheimer's dementia within five years.

Updated Nov 1

Lab-grown retinas reveal how the eye builds its sharpest vision

New Capabilities

Home institution of the study

The foveola is a sliver of tissue at the very center of the retina, and the researchers say it accounts for roughly half of human visual perception. It also has an odd composition: it holds red and green cones but no blue ones. Johns Hopkins scientists grew that region in a dish and watched it assemble itself, then described a mechanism that contradicts an explanation the field has used for about 30 years.

Updated Oct 31

Scientists identify claudin-4 as receptor for colon cancer-linked bacterial toxin

New Capabilities

Led the claudin-4 study

In 2009, researchers showed that a toxin made by Bacteroides fragilis causes colon tumors in mice. For nearly two decades, no one knew which protein on the surface of colon cells the toxin grabbed to do it.

Updated Oct 31

Magnetic millirobots deliver drugs directly to a beating heart

New Capabilities

Research institution where the millirobots were developed

Johns Hopkins University engineers built a pair of magnetic robots the size of a pencil tip that are designed to travel through the bloodstream and put antibiotics directly on infected heart tissue. The robots carry no batteries or motors; coils outside the body, working on the same principle as an MRI machine, steer them. If it works in patients, the team says the procedure could take under an hour.

Updated Oct 26

MIT researchers build handheld device that collects living cancer cells for testing

New Capabilities

As of September 2026: Clinical collaborator

Standard cancer pathology has a built-in contradiction: tissue is bathed in chemical preservatives before analysis, and those chemicals kill the cells inside it. That leaves pathologists with a good look at dead cells and no way to test how a patient's living cancer responds to drugs.

Updated Sep 24